China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using a Smart Medication Support System to Help Patients on New Dual-Target Immunotherapy Better Manage Treatment Side Effects'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132583

Registration Time: 2026/09/16

Type: Interventional study

Primary Sponsor: Fujian Cancer Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333719

Published by HT Digital Content Services with permission from Health Daily Digest....